Home / Import refusals / AEK-3721854-0/131/1

FDA Import Refusal AEK-3721854-0/131/1 — Ipca Laboratories Ltd

Ipca Laboratories Ltd — FEI 3010070496

The FDA refused shipment AEK-3721854-0/131/1 from Ipca Laboratories Ltd (India) on August 18, 2023. The refused product falls under Drugs and Biologics — LISINOPRIL (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 18, 2023
Country
India
Product Category
Drugs and Biologics
Product Code
62ODY40 LISINOPRIL (ANTI-HYPERTENSIVE - PART II)
Charges
75

Recent inspections

  • 1023662 (VAI Thu Aug 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-9338374-2/30002/1 (Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-2233101-0/40002/3 (Tue Apr 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2069554-7/20003/1 (Tue Mar 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9274982-7/30003/1 (Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4626916-7/10003/1 (Wed Jan 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources